Conference Coverage

The Interdisciplinary Autoimmune Summit brings specialists from different disciplines, including dermatology, rheumatology, and gastroenterology, together to learn how to care for patients with immune-mediated inflammatory diseases. It will be held virtually from July 10 through 12, 2020. Read more for a special discount code.

He talks about how vaccinations affect individuals with immunocompromised immune systems, the challenges associated with vaccination, and what rheumatologists should know about vaccines in 2020.

Rohan Machhar and Dafna D. Gladman, MD, from the Krembil Research Institute, answer our questions about their research on microRNA-21-5p as a potential biomarker to predict which patients with psoriasis will advance to psoriatic arthritis.

Jillian Rose, PhD, MPH, LCSW, and Priscilla Toral, LCSW, both from Hospital for Special Surgery, answer our questions about their research on self-reported needs and concerns of men with systemic lupus erythematosus.

In this video, Vibeke Strand, MD, discusses immunogenicity and its contributing factors among individuals with immune-mediated inflammatory diseases.

Authors of a new study presented at the 2019 ACR/ARP Annual Meeting evaluated the safety and efficacy of immune checkpoint inhibitor therapy in patients with preexisting autoimmune diseases.

Authors of a new study determined whether patients with irritable bowel syndrome could experience symptom relief with fecal microbiota transplantation from a single donor with a favorable microbiota profile. The findings were presented at UEG Week 2019.

At the 2019 Fall Clinical Dermatology Conference, Alice B. Gottlieb, MD, and Joseph F. Merola, MD, presented on how to diagnosis psoriatic arthritis in patients with psoriasis.